New research suggests diabetes drug could slow Alzheimer’s progression

A new study published in the journal Neurology is reporting an association between a particular class of drugs used to treat type 2 diabetes and decreased Alzheimer’s disease biomarkers. It is unclear exactly how these diabetes drugs could exert neuroprotective effects, but Alzheimer’s experts are calling for large-scale clinical trials to explore these potential treatments in non-diabetic groups.
Tags: Diabetes, Dementia, Alzheimer’s Disease, Brain, Neuroscience, New Atlas Audio
Continue reading New research suggests diabetes drug could slow Alzheimer’s progression

